title: [Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection].
authors.forename: Jacek
authors.initials: J
authors.lastname: Juszczyk
authors.forename: Anna
authors.initials: A
authors.lastname: Boroń-Kaczmarska
authors.forename: Janusz
authors.initials: J
authors.lastname: Cianciara
authors.forename: Robert
authors.initials: R
authors.lastname: Flisiak
authors.forename: Andrzej
authors.initials: A
authors.lastname: Gładysz
authors.forename: Waldemar
authors.initials: W
authors.lastname: Halota
authors.forename: Wiesław
authors.initials: W
authors.lastname: Kryczka
authors.forename: Piotr
authors.initials: P
authors.lastname: Małkowski
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Pawłowska
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Simon
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D019468:Disease Management; D006297:Health Services Accessibility / Q000458:organization & administration; D006509:Hepatitis B / Q000188:drug therapy; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D011044:Poland; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000458:organization & administration; D011320:Primary Health Care / Q000458:organization & administration*; D011994:Recombinant Proteins
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D019259:Lamivudine